Cargando…
The Evidence for Hypoperfusion as a Factor in Multiple Sclerosis Lesion Development
The evidence that hypoxia is a precipitating factor in causing early MS lesions includes increased protein levels of hypoxia-inducible factor-1α; presence of the D-110 hypoxia-inducible protein; increased expression of hypoxia-inducible genes in lesions as well as in adjacent normal-appearing white...
Autor principal: | Juurlink, Bernhard H. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3649777/ https://www.ncbi.nlm.nih.gov/pubmed/23691321 http://dx.doi.org/10.1155/2013/598093 |
Ejemplares similares
-
The Role of Cerebral Hypoperfusion in Multiple Sclerosis (ROCHIMS) Trial in Multiple Sclerosis: Insights From Negative Results
por: Hostenbach, Stéphanie, et al.
Publicado: (2020) -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-Remitting Multiple Sclerosis
por: Koudriavtseva, Tatiana, et al.
Publicado: (2020) -
Pathophysiology of multiple sclerosis damage and repair: Linking cerebral hypoperfusion to the development of irreversible tissue loss in multiple sclerosis using magnetic resonance imaging
por: Mascali, Daniele, et al.
Publicado: (2023) -
The relevance of cortical lesions in patients with multiple sclerosis
por: Geisseler, Olivia, et al.
Publicado: (2016) -
Role of cerebral hypoperfusion in multiple sclerosis (ROCHIMS): study protocol for a proof-of-concept randomized controlled trial with bosentan
por: Hostenbach, Stéphanie, et al.
Publicado: (2019)